• July 7th, 2020 – After two years of working on what has been purely a scientific endeavour, Coen Maas, Steven de Maat, Kristof Vercruysse and Marc van Moorsel have now officially founded TargED Biopharmaceuticals B.V. as UMC Utrecht spin-off. Why this name? Because TargED actually covers what we provide: Targeted Enzyme Delivery.